Trust Chemists And Druggists Profile
Key Indicators
- Authorised Capital ₹ 71.75 Cr
as on 16-11-2024
- Paid Up Capital ₹ 71.70 Cr
as on 16-11-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.22 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-11-2024
About Trust Chemists And Druggists
The Corporate was formerly known as Trust Chemists And Druggists Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 71.75 Cr and a paid-up capital of Rs 71.70 Cr.
The company currently has active open charges totaling ₹20.22 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemanth Bothra, Dinyar Elavia, and Leela Kanwar serve as directors at the Company.
- CIN/LLPIN
U51397KA2003PTC031802
- Company No.
031802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2003
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Trust Chemists And Druggists?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemanth Bothra  | Managing Director | 09-Jun-2003 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinyar Elavia | Nominee Director | 11-Jan-2024 | Current |
| Leela Kanwar | Director | 01-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Trust Chemists And Druggists.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Trust Chemists And Druggists?
Unlock access to Trust Chemists And Druggists's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vnurture Healthcare Software Solutions Private LimitedActive 17 years 11 monthsDinyar Elavia is a mutual person
Lyrus Life Sciences Private LimitedActive 9 years 6 monthsHemanth Bothra and Leela Kanwar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Mysore Creation Date: 20 Jan 2004 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 20 Jan 2004 | ₹19.22 Cr | Open |
State Bank Of Indore Creation Date: 18 Oct 2005 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Trust Chemists And Druggists?
Unlock and access historical data on people associated with Trust Chemists And Druggists, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trust Chemists And Druggists, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trust Chemists And Druggists's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
